dc.contributor.author |
Rausch, Steffen |
de_DE |
dc.contributor.author |
Schwentner, Christian |
de_DE |
dc.contributor.author |
Stenzl, Arnulf |
de_DE |
dc.contributor.author |
Bedke, Jens |
de_DE |
dc.date.accessioned |
2015-07-06T11:31:26Z |
|
dc.date.available |
2015-07-06T11:31:26Z |
|
dc.date.issued |
2014 |
de_DE |
dc.identifier.issn |
2164-5515 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/64136 |
|
dc.language.iso |
en |
en |
dc.publisher |
Landes Bioscience |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.4161/hv.29553 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20150423052756_00482 |
de_DE |
utue.publikation.seiten |
3146-3152 |
de_DE |
utue.personen.roh |
Rausch, Steffen |
de_DE |
utue.personen.roh |
Schwentner, Christian |
de_DE |
utue.personen.roh |
Stenzl, Arnulf |
de_DE |
utue.personen.roh |
Bedke, Jens |
de_DE |
dcterms.isPartOf.ZSTitelID |
Human Vaccines & Immunotherapeutics |
de_DE |
dcterms.isPartOf.ZS-Issue |
11 |
de_DE |
dcterms.isPartOf.ZS-Volume |
10 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |